Literature DB >> 20127211

Quantitative determination of hydrate content of theophylline powder by chemometric X-ray powder diffraction analysis.

Makoto Otsuka1, Hajime Kinoshita.   

Abstract

The purpose of this study was to establish a calibration model to predict the hydrate content in powder materials consisting of anhydrate (theophylline anhydrate (THA)) and theophylline monohydrate (THM) by using various kinds of X-ray powder diffraction (XRPD) analytical methods. XRPD profiles were measured five times each for 11 standard samples containing of THA and THM. THM content in the standard samples was evaluated based on XRPD profiles by the diffraction peak height and area methods, and the Wakelin's and principal component regression (PCR) methods, respectively. Since THA and THM were cube- and rod-shaped particles, the standard samples consisted of THA and THM showed crystal orientation due to THM crystal shape. THA showed reproducible XRPD profiles, but THM showed fluctuating intensities in some specific peaks in the profiles. The linear calibration models were evaluated based on calibration XRPD datasets of the standard materials by various methods. In the result based on validation XRPD datasets, the order of the mean bias and the mean accuracy were peak height > peak area > Wakelin's > PCR, indicating that PCR was the best method to correct sample crystal orientation. The effectiveness of the PCR method in construction of calibration models was discussed by a scientific approach based on regression vectors.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20127211      PMCID: PMC2850470          DOI: 10.1208/s12249-009-9357-4

Source DB:  PubMed          Journal:  AAPS PharmSciTech        ISSN: 1530-9932            Impact factor:   3.246


  11 in total

1.  A novel method for analyzing thick tablets by near infrared spectroscopy.

Authors:  J L Ramirez; M K Bellamy; R J Romañac
Journal:  AAPS PharmSciTech       Date:  2001-07-12       Impact factor: 3.246

2.  International Conference on Harmonisation; guidance on Q6A specifications: test procedures and acceptance criteria for new drug substances and new drug products: chemical substances. Notice.

Authors: 
Journal:  Fed Regist       Date:  2000-12-29

3.  DISSOLUTION BEHAVIOR OF CRYSTALLINE SOLVATED AND NONSOLVATED FORMS OF SOME PHARMACEUTICALS.

Authors:  E SHEFTER; T HIGUCHI
Journal:  J Pharm Sci       Date:  1963-08       Impact factor: 3.534

4.  An accurate quantitative analysis of polymorphs based on artificial neural networks.

Authors:  Takehiro Okumura; Masayuki Nakazono; Makoto Otsuka; Kozo Takayama
Journal:  Colloids Surf B Biointerfaces       Date:  2006-04-18       Impact factor: 5.268

Review 5.  Pharmaceutical applications of polymorphism.

Authors:  J Haleblian; W McCrone
Journal:  J Pharm Sci       Date:  1969-08       Impact factor: 3.534

6.  A novel standard sample powder preparation method for quantitative analysis of polymorphs.

Authors:  Takehiro Okumura; Makoto Otsuka
Journal:  J Pharm Sci       Date:  2005-05       Impact factor: 3.534

7.  An automated parallel crystallisation search for predicted crystal structures and packing motifs of carbamazepine.

Authors:  Alastair J Florence; Andrea Johnston; Sarah L Price; Harriott Nowell; Alan R Kennedy; Norman Shankland
Journal:  J Pharm Sci       Date:  2006-09       Impact factor: 3.534

8.  Processing-induced phase transitions of theophylline--implications on the dissolution of theophylline tablets.

Authors:  Jaidev S Tantry; Jitesh Tank; Raj Suryanarayanan
Journal:  J Pharm Sci       Date:  2007-05       Impact factor: 3.534

9.  Effect of surface characteristics of theophylline anhydrate powder on hygroscopic stability.

Authors:  M Otsuka; N Kaneniwa; K Kawakami; O Umezawa
Journal:  J Pharm Pharmacol       Date:  1990-09       Impact factor: 3.765

10.  Simultaneous spectrophotometric determination of pseudoephedrine hydrochloride and ibuprofen in a pharmaceutical preparation using ratio spectra derivative spectrophotometry and multivariate calibration techniques.

Authors:  I Murat Palabiyik; Erdal Dinç; Feyyaz Onur
Journal:  J Pharm Biomed Anal       Date:  2004-02-18       Impact factor: 3.935

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.